Skip to content

Vaxcyte, Inc.

PCVX· NasdaqCore metricsCIK 1649094

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -5.76%
Market cap
$10.24B
158.3M shares
Filings
772
—
—
—
-$297.06M
Q3 2026N/M FY25 yoy
-$308.27M
Q3 2026N/M FY25 yoy
-$746.94M
Q3 2026derivedN/M FY25 yoy
-$1.99
Q3 2026N/M FY25 yoy
$125.47M
Q3 2026−55.2% FY25 yoy
$10.24B
—
—
4.1×
-6.54%
—

FY2025 figures · derived

Price

$64.67+41.66%+$19.02past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$794.31MFY 2025
$794.31M0FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$794,306,000reported
FY 20242024-12-31$476,644,000reported
FY 20232023-12-31$332,341,000reported
FY 20222022-12-31$169,451,000reported
FY 20212021-12-31$78,411,000reported
FY 20202020-12-31$73,564,000reported
FY 20192019-12-31$45,607,000reported
FY 20182018-12-31$30,145,000reported

Segments

Geography
Long-lived assets by Geography, FY2023 to FY2025FY2023UNITED STATES · FY2023 · $79.60MFY2024SWITZERLAND · FY2024 · $157.20MUNITED STATES · FY2024 · $40.80MFY2025SWITZERLAND · FY2025 · $217.70MUNITED STATES · FY2025 · $39.70M
LineFY2025ShareChange
SWITZERLAND$217.70M85%+38.5%
UNITED STATES$39.70M15%−2.7%
Total$257.37M

From the 10-Q filed Nov 4, 2026PCVX

Biological products, except diagnostic substances

Vaxcyte, Inc. is the 15th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Vaxcyte, Inc. · CIK 1649094 · Engraved from SEC EDGAR